(株)デ・ウエスタン・セラピテクス研究所の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4576/E22024D.Western Therapeutics Institute, Inc.
公表日公表担保貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比
2016/09/16日証協無担保0株0%0株0%658,799株+0.98%
2016/09/16日証協有担保1,587,960株+0.24%207,300株0%726,000株+0.23%
2016/09/09日証協無担保0株0%0株0%652,399株-1.6%
2016/09/09日証協有担保1,584,160株-0.03%207,300株0%724,300株-0.48%
2016/09/02日証協無担保0株0%0株0%662,999株+2.47%
2016/09/02日証協有担保1,584,660株+0.83%207,300株+1.17%727,800株+0.01%
2016/08/26日証協無担保0株0%0株0%646,999株-1.08%
2016/08/26日証協有担保1,571,660株-1.39%204,900株-0.49%727,700株-2.49%
2016/08/19日証協無担保0株0%0株0%654,094株+3.01%
2016/08/19日証協有担保1,593,760株-1.04%205,900株-0.82%746,300株-0.55%
2016/08/12日証協無担保0株0%0株0%634,974株-0.14%
2016/08/12日証協有担保1,610,460株+0.71%207,600株+0.58%750,400株-0.23%
2016/08/05日証協無担保0株0%0株0%635,888株+3.87%
2016/08/05日証協有担保1,599,160株-4.81%206,400株-22.46%752,100株+2.12%
2016/07/29日証協無担保0株0%0株0%612,188株-2.92%
2016/07/29日証協有担保1,679,960株-6.32%266,200株-27.76%736,500株+0.37%
2016/07/22日証協無担保0株0%0株0%630,588株-0.02%
2016/07/22日証協有担保1,793,260株+12.14%368,500株+36.89%733,800株+7.06%
2016/07/15日証協無担保0株0%0株0%630,688株+1.79%
2016/07/15日証協有担保1,599,160株-3.31%269,200株-14.59%685,400株-1.82%
2016/07/08日証協無担保0株0%0株0%619,588株+1.03%
2016/07/08日証協有担保1,653,960株-0.88%315,200株0%698,100株-0.07%
2016/07/01日証協無担保0株0%0株0%613,244株+1.68%
2016/07/01日証協有担保1,668,560株-1.06%315,200株+0.13%698,600株-1.31%
2016/06/24日証協無担保0株0%0株0%603,088株+0.57%
2016/06/24日証協有担保1,686,360株-6.17%314,800株-0.29%707,900株-11.91%
2016/06/17日証協無担保0株0%0株0%599,653株-2.65%
2016/06/17日証協有担保1,797,260株+2.81%315,700株+25.23%803,600株+6.54%
2016/06/10日証協無担保0株0%0株0%615,953株+0.66%
2016/06/10日証協有担保1,748,080株-0.93%252,100株+2.77%754,300株-1.71%
2016/06/03日証協無担保0株0%0株0%611,938株-1.45%
2016/06/03日証協有担保1,764,480株+16.58%245,300株-13.81%767,400株+24.09%
2016/05/27日証協無担保0株0%0株0%620,938株+3.16%
2016/05/27日証協有担保1,513,560株-1.17%284,600株+21.68%618,400株-5.17%
2016/05/20日証協無担保0株0%0株0%601,938株+0.45%
2016/05/20日証協有担保1,531,480株-2.15%233,900株+59.55%652,100株-10.88%
2016/05/13日証協無担保0株0%0株-100%599,218株-3.94%
2016/05/13日証協有担保1,565,180株-8.77%146,600株+37.52%731,700株-11.58%

※株式分割は考慮していませんのでご注意ください。

Page Top